Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Featured here, the Income Statement (earnings report) for Glaxo Smith Kline, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

Teva Pharmaceutical Industries Ltd. ADR 1.10% $20.47B ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Shares in GSK fell around 9% this morning after a judge ... The company and other pharma groups that have sold ranitidine products over the years have so far been fairly successful in fending ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 43,685.58 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year, up 15%. COPD could open up a massive new market for the drug, which still has ...